Abstract
To acquire a functional view of human autoimmunity, we compared differences in gene expression (≥4000 genes) in the peripheral blood mononuclear cells of normal individuals following immunization to those in individuals with four different autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, insulin dependent diabetes mellitus, and multiple sclerosis). Each individual from all disease groups displayed a similar pattern of gene expression that was highly distinct from the gene expression pattern of the immunized group. These findings indicate that the expression pattern accompanying autoimmunity is not simply a recapitulation of the immune response to non-self. Of note, expression levels of genes that encode key proteins in several distinct apoptosis pathways were markedly reduced in all autoimmune disease groups. Taken together, these data indicate that the pattern of gene expression describes a molecular portrait of autoimmunity that is constant among individuals with autoimmune disease but is independent of the specific autoimmune disease and the clinical parameters associated with any individual autoimmune disease.
Keywords: gene expression profiles, autoimmune disease, human autoimmunity, rheumatoid arthritis, systemic lupus erythematosus, insulin dependent diabetes, multiple sclerosis
Current Pharmaceutical Design
Title: Gene Expression Profiles in Human Autoimmune Disease
Volume: 9 Issue: 23
Author(s): Thomas M. Aune, Kevin Maas, Jason H. Moore and Nancy J. Olsen
Affiliation:
Keywords: gene expression profiles, autoimmune disease, human autoimmunity, rheumatoid arthritis, systemic lupus erythematosus, insulin dependent diabetes, multiple sclerosis
Abstract: To acquire a functional view of human autoimmunity, we compared differences in gene expression (≥4000 genes) in the peripheral blood mononuclear cells of normal individuals following immunization to those in individuals with four different autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, insulin dependent diabetes mellitus, and multiple sclerosis). Each individual from all disease groups displayed a similar pattern of gene expression that was highly distinct from the gene expression pattern of the immunized group. These findings indicate that the expression pattern accompanying autoimmunity is not simply a recapitulation of the immune response to non-self. Of note, expression levels of genes that encode key proteins in several distinct apoptosis pathways were markedly reduced in all autoimmune disease groups. Taken together, these data indicate that the pattern of gene expression describes a molecular portrait of autoimmunity that is constant among individuals with autoimmune disease but is independent of the specific autoimmune disease and the clinical parameters associated with any individual autoimmune disease.
Export Options
About this article
Cite this article as:
Aune M. Thomas, Maas Kevin, Moore H. Jason and Olsen J. Nancy, Gene Expression Profiles in Human Autoimmune Disease, Current Pharmaceutical Design 2003; 9 (23) . https://dx.doi.org/10.2174/1381612033454360
DOI https://dx.doi.org/10.2174/1381612033454360 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Perinatal Depression, Fetal Bonding, and Mother-Child Attachment: A Review of the Literature
Current Pediatric Reviews In vitro Anti-glycation and Anti-oxidant Properties of Synthesized Schiff Bases
Medicinal Chemistry Ontologies of Drug Discovery and Design for Neurology, Cardiology and Oncology
Current Pharmaceutical Design Hydrogels Based on Interpenetrating Network of Chitosan and Polyvinyl Pyrrolidone for pH-Sensitive Delivery of Repaglinide
Current Drug Discovery Technologies Polypharmacy in Cardiovascular Medicine: Problems and Promises!
Cardiovascular & Hematological Agents in Medicinal Chemistry Purification of Paraoxonase Enzyme From the Sera of Patients with Behcet’s Disease and Analyzing the Effects of the Drugs Containing Imuran (Azathioprine), Prednisolone (Methylprednisolone) and Colchium (Colchicine)
Drug Metabolism Letters Surgical or Interventional Revascularization in Diabetic Patients with Coronary Artery Disease?
Current Diabetes Reviews Bone Disruption and Environmental Pollutants
Endocrine, Metabolic & Immune Disorders - Drug Targets Sensors Based On Carbon Nanotubes and Their Applications: A Review
Current Nanoscience Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance
Current Neuropharmacology Hyperglycemia Induced Changes in Liver: In vivo and In vitro Studies
Current Diabetes Reviews Selenium in the Therapy of Neurological Diseases. Where is it Going?
Current Neuropharmacology Osteoporosis Requires Bone-Specific Statins
Current Pharmaceutical Design Benzothiazole Derivatives: Novel Inhibitors of Methylglyoxal Mediated Glycation of Proteins In Vitro
Medicinal Chemistry Foreword:
Current Pharmaceutical Design Disparities in Cardiovascular Disease Risk in the United States
Current Cardiology Reviews Therapeutical Relevance of MAP-Kinase Inhibitors in Renal Diseases: Current Knowledge and Future Clinical Perspectives
Current Medicinal Chemistry Mitochondrial Biogenesis in Health and Disease. Molecular and Therapeutic Approaches
Current Pharmaceutical Design Consequences of Type 1 and 2 Diabetes Mellitus on the Cardiovascular Regulation During Exercise: A Brief Review
Current Diabetes Reviews A Review of Type 2 Diabetes Mellitus Predisposing Genes
Current Diabetes Reviews